Ingestible sensor system for measuring, monitoring and enhancing adherence to antiretroviral therapy: An open-label, usual care-controlled, randomised trial

By sjmartinez • November 14, 2022

Liu H, Wang Y, Huang Y, Xiong D, Shen J, Siqueiros L, Bala V, Savage GM, Guerrero M, Corado K, Rosen MI, Fletcher CV, Daar ES. Ingestible sensor system for measuring, monitoring and enhancing adherence to antiretroviral therapy: An open-label, usual care-controlled, randomised trial. EBioMedicine. 2022 Nov 8:104330. doi: 10.1016/j.ebiom.2022.104330. Epub ahead of print. PMID: 36372731.

Tags: Adherence, General Internal Medicine, HIV, Infectious Diseases, Ingestible sensor, Pharmacokinetic, Publications, viral load

Genetic Research within Indigenous Communities: Engagement Opportunities and Pathways Forward

Barton KS, Porter KM, Mai T, Claw KG, Hiratsuka VY, Carroll SR, Burke W, Garrison NA. Genetic Research within Indigenous Communities: Engagement Opportunities and Pathways[...]

Atypical functional connectivity between the amygdala and visual, salience regions in infants with genetic liability for autism

Liu J, Girault JB, Nishino T, Shen MD, Kim SH, Burrows CA, Elison JT, Marrus N, Wolff JJ, Botteron KN, Estes AM, Dager SR, Hazlett[...]

Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019

Bramante CT, Beckman KB, Mehta T, Karger AB, Odde DJ, Tignanelli CJ, Buse JB, Johnson DM, Watson RHB, Daniel JJ, Liebovitz DM, Nicklas JM, Cohen[...]